These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7205639)

  • 1. Inhibition of two monomeric butyrylcholinesterases from rabbit liver by chlorpromazine and other drugs.
    Rush RS; Main AR; Kilpatrick BF; Faulkner GD
    J Pharmacol Exp Ther; 1981 Mar; 216(3):586-91. PubMed ID: 7205639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bambuterol, a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterases in human blood.
    Tunek A; Svensson LA
    Drug Metab Dispos; 1988; 16(5):759-64. PubMed ID: 2906603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Butyrylcholinesterase: inhibition by arsenite, fluoride, and other ligands, cooperativity in binding.
    Page JD; Wilson IB; Silman I
    Mol Pharmacol; 1985 Apr; 27(4):437-43. PubMed ID: 3982389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kinetics of reversible inhibition of cholinesterases by quaternary diaminoalkyl esters of aromatic dicarboxylic acids].
    Volkova RI; Dmitrieva EN
    Biokhimiia; 1976 Mar; 41(3):443-51. PubMed ID: 1276277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic model of ethopropazine interaction with horse serum butyrylcholinesterase and its docking into the active site.
    Golicnik M; Sinko G; Simeon-Rudolf V; Grubic Z; Stojan J
    Arch Biochem Biophys; 2002 Feb; 398(1):23-31. PubMed ID: 11811945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the butyrylcholinesterase by ethidium bromide.
    Patocka J
    Biomed Biochim Acta; 1987; 46(11):769-74. PubMed ID: 3446203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aprophen: a substrate and inhibitor of butyrylcholinesterase and carboxylesterases.
    Rush RS; Ralston JS; Wolfe AD
    Biochem Pharmacol; 1985 Jun; 34(12):2063-8. PubMed ID: 4004924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slow-binding inhibition of gamma-aminobutyric acid aminotransferase by hydrazine analogues.
    Lightcap ES; Silverman RB
    J Med Chem; 1996 Feb; 39(3):686-94. PubMed ID: 8576911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the inhibition of cholinesterases by pancuronium (author's transl)].
    Schuh FT
    Anaesthesist; 1977 Mar; 26(3):125-9. PubMed ID: 855909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Estimation of anticholinesterase activity in reversible inhibitors of cholinesterase hydrolysis].
    Brestkin AP; Kuznetsova LP; Rozengart EV
    Ukr Biokhim Zh (1978); 1994; 66(1):66-72. PubMed ID: 7974841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
    Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
    Biochemistry; 1997 Dec; 36(48):14642-51. PubMed ID: 9398183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition Effects in the Hydrolysis Reactions of Esters and Peptides Catalyzed by Carboxypeptidase A: An Example of Cooperative Binding Effects with a Monomeric Enzyme.
    Rahmo A; Fife TH
    Bioorg Chem; 2000 Aug; 28(4):226-241. PubMed ID: 11034784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of two different cholinesterases by tacrine.
    Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
    Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Doxylstearate-induced displacement of phencyclidine from its low-affinity binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Arch Biochem Biophys; 1999 Nov; 371(1):89-97. PubMed ID: 10525293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-reactivity relationships for the inhibition mechanism at the second alkyl-chain-binding site of cholesterol esterase and lipase.
    Lin G; Shieh CT; Ho HC; Chouhwang JY; Lin WY; Lu CP
    Biochemistry; 1999 Aug; 38(31):9971-81. PubMed ID: 10433704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric human cholinesterase. Identification of interaction sites responsible for recognition of acetyl- or butyrylcholinesterase-specific ligands.
    Loewenstein Y; Gnatt A; Neville LF; Soreq H
    J Mol Biol; 1993 Nov; 234(2):289-96. PubMed ID: 8230213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human 5-phosphoribosyl-1-pyrophosphate synthetase by 4-amino-8-(beta-D-ribofuranosylamino)-pyrimido[5,4-d]pyrimidine-5'- monophosphate: evidence for interaction at the ADP allosteric site.
    Fry DW; Becker MA; Switzer RL
    Mol Pharmacol; 1995 Apr; 47(4):810-5. PubMed ID: 7723742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of tricyclic drug analogs with synaptic plasma membranes: structure-mechanism relationships in inhibition of neuronal Na+/K(+)-ATPase activity.
    Carfagna MA; Muhoberac BB
    Mol Pharmacol; 1993 Jul; 44(1):129-41. PubMed ID: 8393517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of interactions of cholinesterases with tight binding inhibitors.
    Radić Z; Manetsch R; Krasiński A; Raushel J; Yamauchi J; Garcia C; Kolb H; Sharpless KB; Taylor P
    Chem Biol Interact; 2005 Dec; 157-158():133-41. PubMed ID: 16289416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.